PT  - JOURNAL ARTICLE
AU  - Tartaglia, Nicole
AU  - Davis, Shanlee
AU  - Howell, Susan
AU  - Bothwell, Samantha
AU  - Nocon, Kayla
AU  - Kowal, Karen
AU  - Ikomi, Chijioke
AU  - Keene, Andrew
AU  - Reynolds, Victoria
AU  - Berglund, Agnethe
AU  - Ross, Judith
TI  - Medical Findings in Infants Prenatally Identified with Sex Chromosome Trisomy in Year One of Life
AID  - 10.1101/2024.07.10.24310206
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.10.24310206
4099  - http://medrxiv.org/content/early/2024/07/10/2024.07.10.24310206.short
4100  - http://medrxiv.org/content/early/2024/07/10/2024.07.10.24310206.full
AB  - BACKGROUND AND OBJECTIVE Sex chromosome trisomies (SCT), including XXY, XYY, and XXX syndromes, have been historically underdiagnosed. Noninvasive prenatal cell-free DNA screening has significantly increased identification of these conditions, leading to a need for pediatric care for a growing population of newborns with SCT. Our goal was to analyze and compare perinatal features, medical diagnoses, and physical features in infants with prenatal identification of SCT conditions through the first year of life.METHODS The eXtraordinarY Babies Study is an ongoing, prospective natural history study of prenatally identified children with SCT conducted by interdisciplinary teams in Colorado and Delaware. Participants were enrolled prior to 12 months of age and had pregnancy, birth, medical histories, and physical exams completed by board-certified pediatricians at 2, 6, and/or 12-month visits. Descriptive statistics were followed by comparisons between SCT groups using t-tests or ANOVA, Fisher exact, and correlations between medical features with alpha of 0.05. Relative risks were calculated compared to general population rates.RESULTS 327 infants were included in the analysis (XXY=195, XXX=79, XYY=53). Major congenital anomalies were rare (1.7%). Relative risk compared to general population was elevated for breastfeeding difficulties (51.7%;RR 2.7), positional torticollis (28.2%;RR 7.2), eczema (48.0%;RR 3.5), food allergies (19.3%;RR 2.4), constipation requiring intervention (33.9%;RR 7.6), small cardiac septal defects (7.7%;RR 17.2), and structural renal abnormalities (4.4%;RR 9.7). Inpatient hospitalization was required for 12.4%, with 59.5% of hospitalizations attributable to respiratory infections.DISCUSSION These findings of medical conditions with a higher prevalence can inform anticipatory guidance and medical management for pediatricians caring for infants with SCT.Article Summary Medical findings in largest cohort of prenatally identified infants with XXY, Trisomy X, and XYY from birth to 12 months and implications for pediatric care.What’s Known on This Subject One in ∼500 individuals have an extra X or Y chromosome, or sex chromosome trisomy (SCT). Prenatal screening is now routinely identifying SCT, however there are few studies to guide perinatal and infant care for these individuals.What This Study Adds This prospective observational study presents medical features for 327 infants with prenatally identified SCT from birth through the first year of life. Results identify where proactive screenings and/or interventions may be warranted for infants with SCT.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://pubmed.ncbi.nlm.nih.gov/32506668/ Funding StatementThis study was funded by NIH NICHD R01HD091251, NIH NICHD K23HD092588, NIH NCATS Colorado CTSA Grant Number UL1 TR002535.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Colorado Multiple Institution Review Board (COMIRB) gave ethical approval for this work Ethics committee/IRB of Nemours Children's Hospital gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study will be available through NICHD DASHAGAAverage for gestational ageAMAAdvanced maternal ageASDAtrial septal defectBWBirth weightBLBirth lengthCDCCenters for Disease ControlCOMIRBColorado Multiple Institutional Review BoardCVSChorionic villus samplingGUGenitourinaryLGALarge for gestational ageNICUNeonatal Intensive Care UnitPEPressure equalizingSCTSex chromosome trisomiesSGASmall for gestational ageVSDVentricular septal defect